Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in EW — Edwards Lifesciences Corp

CIK 886982 NEW YORK, NY
Back to EW Full portfolio

Position in EW

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$406,970,562
+$125,329,117 QoQ
Shares Held
5,082,050
+53.8% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 94.52892041597387.ToString("F0")% Shared 0.25454295018742434.ToString("F0")% None 5.2165366338387065.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$4,804,800
PutShares
60,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. EW ranks #5 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 14,505,201 $1,489,248,984
2 BSX
Boston Scientific Corp
 18,891,624 $1,185,449,403
3 SYK
Stryker Corp
 2,669,835 $877,281,079
4 MDT
Medtronic plc
 5,600,590 $485,291,119
5 EW
Edwards Lifesciences Corp
This page 		5,082,050 $406,970,562
6 PEN
Penumbra Inc
 720,575 $236,615,212
7 GEHC
GE HealthCare Technologies Inc.
 3,266,138 $232,483,701
8 DXCM
Dexcom Inc
 3,043,635 $191,140,276

All Filings in EW

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $406,970,562 5,082,050
2026-03-31 $4,804,800 60,000
2025-12-31 $2,983,750 35,000
2025-12-31 $281,641,445 3,303,712
2025-12-31 $13,640,000 160,000
2025-09-30 $2,721,950 35,000
2025-09-30 $223,938,324 2,879,495
2025-09-30 $1,749,825 22,500
2025-06-30 $2,737,350 35,000
2025-06-30 $1,759,725 22,500
2025-06-30 $213,501,410 2,729,848
2025-03-31 $185,118,918 2,554,069
2025-03-31 $2,536,800 35,000
2025-03-31 $1,630,800 22,500
2024-12-31 $2,591,050 35,000
2024-12-31 $162,344,678 2,192,958
2024-09-30 $212,103,537 3,214,177
2024-06-30 $369,883,746 4,004,371
2024-03-31 $334,478,535 3,500,194
2023-12-31 $267,877,304 3,513,145
2023-09-30 $239,768,585 3,460,863
2023-06-30 $445,128,550 4,718,844
2023-03-31 $391,781,314 4,735,662
2022-12-31 $255,681,975 3,426,913
2022-09-30 $269,391,564 3,260,215
2022-06-30 $286,253,227 3,010,340
2022-03-31 $294,736,738 2,503,710
2021-12-31 $1,580,510 12,200
2021-12-31 $363,944,940 2,809,301
2021-09-30 $9,056,800 80,000
2021-09-30 $313,659,283 2,770,597
2021-06-30 $245,758,764 2,372,876
2021-06-30 $8,285,600 80,000
2021-03-31 $230,602,753 2,757,087
2020-12-31 $274,131,093 3,004,835
2020-09-30 $381,131,556 4,774,888
2020-09-30 $1,173,354 14,700
2020-06-30 $1,368,378 19,800
2020-06-30 $1,119,582 16,200
2020-06-30 $385,348,856 5,575,877
2020-03-31 $120,160,430 1,911,152
2020-03-31 $2,351,461 37,400
2020-03-31 $440,113 7,000

Report a Problem

Category
Description
Email (optional, for follow-up)